These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 11464906)
21. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979 [TBL] [Abstract][Full Text] [Related]
22. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859 [TBL] [Abstract][Full Text] [Related]
23. Detailed molecular analysis of 1p36 in neuroblastoma. White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901 [TBL] [Abstract][Full Text] [Related]
24. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Ambros PF; Ambros IM; Kerbl R; Luegmayr A; Rumpler S; Ladenstein R; Amann G; Kovar H; Horcher E; De Bernardi B; Michon J; Gadner H Med Pediatr Oncol; 2001 Jan; 36(1):1-4. PubMed ID: 11464855 [TBL] [Abstract][Full Text] [Related]
25. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis. Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802 [TBL] [Abstract][Full Text] [Related]
26. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group. Christiansen H; Delattre O; Fuchs S; Theobald M; Christiansen NM; Berthold F; Lampert F Prog Clin Biol Res; 1994; 385():19-25. PubMed ID: 7972212 [TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity for chromosome 14q in neuroblastoma. Thompson PM; Seifried BA; Kyemba SK; Jensen SJ; Guo C; Maris JM; Brodeur GM; Stram DO; Seeger RC; Gerbing R; Matthay KK; Matise TC; White PS Med Pediatr Oncol; 2001 Jan; 36(1):28-31. PubMed ID: 11464899 [TBL] [Abstract][Full Text] [Related]
28. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247 [TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2. Fransson S; Martinsson T; Ejeskär K Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048 [TBL] [Abstract][Full Text] [Related]
30. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Caron H; Peter M; van Sluis P; Speleman F; de Kraker J; Laureys G; Michon J; Brugières L; Voûte PA; Westerveld A Hum Mol Genet; 1995 Apr; 4(4):535-9. PubMed ID: 7633401 [TBL] [Abstract][Full Text] [Related]
31. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma. Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268 [TBL] [Abstract][Full Text] [Related]
32. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177 [TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines. Mathysen D; Van Roy N; Van Hul W; Laureys G; Ambros P; Speleman F; Wuyts W Eur J Cancer; 2004 May; 40(8):1255-61. PubMed ID: 15110891 [TBL] [Abstract][Full Text] [Related]
34. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis. Zahn S; Sievers S; Alemazkour K; Orb S; Harms D; Schulz WA; Calaminus G; Göbel U; Schneider DT Genes Chromosomes Cancer; 2006 Nov; 45(11):995-1006. PubMed ID: 16897744 [TBL] [Abstract][Full Text] [Related]
35. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646 [TBL] [Abstract][Full Text] [Related]
36. Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma. Theobald M; Christiansen H; Schmidt A; Melekian B; Wolkewitz N; Christiansen NM; Brinkschmidt C; Berthold F; Lampert F Genes Chromosomes Cancer; 1999 Sep; 26(1):40-6. PubMed ID: 10441004 [TBL] [Abstract][Full Text] [Related]
37. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore. Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166 [TBL] [Abstract][Full Text] [Related]